Australia markets close in 5 hours 13 minutes

Genetic Signatures Limited (GSS.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
1.16500.0000 (0.00%)
As of 03:43PM AEST. Market open.

Genetic Signatures Limited

7 Eliza Street
Newtown, NSW 2042
Australia
61 2 9870 7580
https://www.geneticsignatures.com

Sector(s):Β Healthcare
Industry:Β Diagnostics & Research
Full-time employees:Β 

Key executives

NameTitlePayExercisedYear born
Dr. John R. Melki BSc, Ph.D.MD, CEO & Exec. Director483.01kN/AN/A
Mr. Peter L. Manley CPACFO & Company Sec.285.37kN/AN/A
Mr. Michael Anton Aicher BSc, M.B.A., MBAExec. Director of US Operations & Exec. Director161.55kN/A1960
Mr. Christopher M. AbbottFounder & Chairman EmeritusN/AN/AN/A
Dr. Douglas S. Millar BSc, Ph.D.Chief Scientific OfficerN/AN/AN/A
Mr. Jackson Jones B.Sc.Director of Global Sales & MarketingN/AN/AN/A
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in Australia, Asia Pacific, North America, Europe, the Middle East, and Africa. It designs and manufactures a suite of real-time polymerase chain reaction-based products for detection of infectious diseases under EasyScreen brand name. The company also provides MDx 3Base platform technology that enables hospital and pathology laboratories to screen for a range of infectious pathogens. In addition, it offers detection kits for gastrointestinal infections, respiratory pathogens, sexual health, anti-microbial resistance, meningitis, and tropical disease. The company was incorporated in 2001 and is headquartered in Newtown, Australia.

Corporate governance

Genetic Signatures Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.